Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Healthy volunteers help test new drug's effect on two common medications

NCT ID NCT07215260

First seen Nov 01, 2025

Summary

This study looked at how a new drug called BI 3000202 changes the way the body handles two other medicines: rosuvastatin (for cholesterol) and digoxin (for heart conditions). Fourteen healthy adults took part to help researchers understand if the new drug could affect how these medications work. The results will guide future dosing recommendations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Humanpharmakologisches Zentrum Biberach

    Biberach, 88397, Germany

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.